SPONSOR
ANRS, Emerging Infectious Diseases
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: TuberculosisTuberculous MeningitisHIV I InfectionHepatitis D, ChronicHepatitis B, ChronicHIV Infections
ANRS, Emerging Infectious Diseases is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Tuberculosis, Tuberculous Meningitis, HIV I Infection, Hepatitis D, Chronic.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — ANRS, Emerging Infectious Diseases
How many clinical trials has ANRS, Emerging Infectious Diseases sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by ANRS, Emerging Infectious Diseases, of which 4 are actively recruiting participants. These trials cover conditions including Tuberculosis, Tuberculous Meningitis, HIV I Infection. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does ANRS, Emerging Infectious Diseases research focus on?
ANRS, Emerging Infectious Diseases clinical trials span Tuberculosis, Tuberculous Meningitis, HIV I Infection, Hepatitis D, Chronic, Hepatitis B, Chronic, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a ANRS, Emerging Infectious Diseases clinical trial?
To participate in a ANRS, Emerging Infectious Diseases trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all ANRS, Emerging Infectious Diseases trials with current recruitment status updated daily.
Clinical Trials by ANRS, Emerging Infectious Diseases
NCT05655702
Recruiting
DRug Use & Infections in ViEtnam: TuBerculosis Control
Tuberculosis
NCT05590455 Phase 2
Recruiting
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Tuberculous Meningitis
NCT04166266
Recruiting
National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
Hepatitis D, Chronic
NCT06302933
Recruiting
Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms
HIV Infections
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology